Felodipine/Ramipril

非洛地平/雷米普利

Report date: 2023/04/21 16:05:16

Base Information

Drug NameFelodipine/Ramipril
Drug Alias Name雷米普利非洛地平Ramipril/FelodipineFelodipine and Ramipril非洛地平雷米普利Ramipril and Felodipine +[11] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date1998/04/07
Country/TerritorySweden
CombinationsYes RamiprilFelodipine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BB05
Related LinksN/A